CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended			24 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2023
Cash flows from operating activities of continuing operations:
Net income	$ 356,328	$ 363,139	$ 485,374
Adjustments to reconcile net income to net cash provided by operating activities:
Loss (income) from discontinued operations	1,244	(223)	(255)
Depreciation expense	68,144	66,502	71,758
Intangible asset amortization expense	173,974	164,088	165,604
Deferred financing costs and debt discount amortization expense	3,400	4,053	4,493
Loss on extinguishment of debt	0	454	12,986
Settlements	45,244	0	0
Fair value step up of acquired inventory sold	1,536	0	3,993
Changes in contingent consideration	(27,243)	2,350	8,475
Assets impairment charges	0	1,497	6,739
Stock-based compensation	31,465	27,224	22,937
Gain on sale of assets and business	(4,448)	(6,504)	(91,157)
Deferred income taxes, net	(13,046)	(13,008)	(110,239)
Payments for contingent consideration	(289)	(3,016)	(230)
Interest benefit on swaps designated as net investment hedges	(18,814)	(20,880)	(19,296)
Other	5,960	(2,906)	(36,388)
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable	(15,763)	(38,459)	(600)
Inventories	(41,068)	(110,686)	(11,138)
Prepaid expenses and other current assets	(11,420)	13,420	(28,410)
Accounts payable, accrued expenses and other liabilities	(31,258)	(24,786)	94,020
Income taxes	(12,263)	(79,453)	73,473
Net cash provided by operating activities from continuing operations	511,683	342,806	652,139
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(91,442)	(79,190)	(71,618)
Payments for businesses and intangibles acquired, net of cash acquired	(603,920)	(198,429)	(4,590)
Proceeds from sales of business and assets	15,000	12,434	224,909
Net interest proceeds on swaps designated as net investment hedges	63,134	20,775	19,154
Proceeds from sales of investments	7,300	7,300	7,300
Purchase of investments	(11,300)	(22,300)	(18,418)
Net cash (used in) provided by investing activities from continuing operations	(621,228)	(259,410)	156,737
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	646,000	744,250	400,000
Reduction in borrowings	(544,750)	(884,500)	(1,034,500)
Debt extinguishment, issuance and amendment fees	0	(5,200)	(9,774)
Net proceeds from share based compensation plans and the related tax impacts	5,190	(4,308)	12,451
Payments for contingent consideration	(4,004)	(3,959)	(31,448)
Dividends paid	(63,896)	(63,789)	(63,648)
Proceeds from sale of treasury stock	0	0	11,097
Net cash provided by (used in) financing activities from continuing operations	38,540	(217,506)	(715,822)
Cash flows from discontinued operations:
Net cash used in operating activities	(1,045)	(665)	(720)
Net cash provided by investing activities	0	1,469	0
Net cash (used in) provided by discontinued operations	(1,045)	804	(720)
Effect of exchange rate changes on cash and cash equivalents	2,864	(19,744)	(23,130)
Net (decrease) increase in cash and cash equivalents	(69,186)	(153,050)	69,204
Cash and cash equivalents at the beginning of the year	292,034	445,084	375,880	$ 445,084
Cash and cash equivalents at the end of the year	$ 222,848	$ 292,034	$ 445,084	$ 222,848